Culturally Tailored HPV Psychoeducational Multimedia Intervention
Implementing Innovative and Strategic Approaches to Prevent and Mitigate the Deleterious Effects of HPV Across the Lifespan of Hispanics of Mexican Origin: Community Intervention
2 other identifiers
interventional
63
1 country
1
Brief Summary
Community members ages 18 - 45 years old from the El Paso, Texas, U.S.-Mexico Border Region will be recruited to compare psychoeducational multimedia interventions focused on the human papillomavirus (HPV). Our hypothesis is that adults who view culturally tailored multimedia stories encouraging HPV vaccination will report higher vaccine uptake rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2023
CompletedFirst Posted
Study publicly available on registry
October 24, 2023
CompletedStudy Start
First participant enrolled
May 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2024
CompletedApril 8, 2026
April 1, 2026
4 months
October 19, 2023
April 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
HPV Vaccination Status
HPV vaccine uptake (yes, no)
Baseline (pre-assessment), 1 month post-intervention
HPV Vaccine Intention Score
HPV vaccine intention score measured on a Likert scale from 1) Strongly disagree to (5) Strongly agree.
Baseline (pre-assessment), immediately post-intervention (0 months), 1 month post-intervention.
Secondary Outcomes (2)
HPV Vaccine Attitude Score
Baseline (pre-assessment), immediately post-intervention (0 months), 1 month post-intervention
HPV Knowledge Score
Baseline (pre-assessment), immediately post-intervention (0 months), 1 month post-intervention
Study Arms (2)
Treatment
EXPERIMENTALA tailored HPV psychoeducational multimedia intervention
Active Control
ACTIVE COMPARATORGeneral/standard multimedia materials on HPV and HPV vaccine
Interventions
The culturally tailored multimedia psychoeducational intervention will involve audio and visual content and will be delivered in a bilingual fashion (English and Spanish) among adults 18-45 years-old.
The general/publicly available multimedia intervention will involve audio and visual content and will be delivered in a bilingual fashion (English and Spanish) among adults 18-45 years-old.
Eligibility Criteria
You may qualify if:
- Adults between the ages 18 and 45 years old
- Adults who have not completed the HPV vaccine series (unvaccinated or under-vaccinated)
- Adults currently living or working in El Paso County, Texas
You may not qualify if:
- Adults who participated in Phases I or II of the larger research project \[cross-sectional phases\]
- Adults younger than 18 years of age
- Adults older than 45 years of age
- Adults that do not reside, plan to live or work in El Paso County, Texas, within the next 12 months after the start of the intervention
- Adults who are unable to participate in the full study intervention and follow-up time-points
- Adults who cannot complete study participation and activities in either the English or Spanish languages.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Texas at El Paso, Border Biomedical Center
El Paso, Texas, 79968, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eva M Moya, PhD, LMSW
The University of Texas at El Paso, Border Biomedical Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- * Participants \[blinding\]: participants will be randomly assigned to treatment and control groups, they will not be made aware of other participant's receipt of treatment or control materials. Participants will be asked not to discuss this project outside of the intervention; delivery of the intervention or other educational materials will be virtual, limiting the ability of participants to interact with one another during the study. * Outcome assessor \[blinding\]: to reduce bias in the implementation and assessment of the clinical trial, participant information and pre-post survey responses will be maintained separately from the assignment and delivery of the intervention.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
October 19, 2023
First Posted
October 24, 2023
Study Start
May 2, 2024
Primary Completion
August 28, 2024
Study Completion
August 28, 2024
Last Updated
April 8, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Approximately, starting 6 months-post scholarly publication of previously listed primary and secondary study outcome(s).
- Access Criteria
- Collected deidentified IPD and supporting information will be provided on a case by case basis following a formal request to the University of Texas at El Paso (UTEP) Institutional Review Board (IRB) and subsequent approval by the Principal Investigator.
Collected deidentified individual participant data (IPD), all IPD that underlie results in a publication.